PHASE II STUDY OF COMBINATION CHEMOTHERAPY WITH ORAL S-1 AND OXALIPLATIN (SOX) IN PATIENTS WITH MUCINOUS ADENOCARCINOMA OF THE OVARY

被引：0
|
作者：
Nishio, S. [1 ]
Shimada, M. [2 ]
Kamura, T. [1 ]
Ishitani, K. [3 ]
Ochiai, K. [4 ]
Takeshima, N. [5 ]
Yokoyama, Y. [6 ]
Furumoto, H. [7 ]
Sugiyama, T. [8 ]
Kigawa, J. [2 ]
机构：
[1] Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan
[2] Tottori Univ, Yonago, Tottori, Japan
[3] Tokyo Womens Med Univ, Tokyo, Japan
[4] Jikei Univ, Sch Med, Tokyo, Japan
[5] Canc Inst Hosp, Tokyo, Japan
[6] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori, Japan
[7] Univ Tokushima, Grad Sch, Tokushima, Japan
[8] Iwate Med Univ, Sch Med, Morioka, Iwate 020, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：326 / 326
页数：1
相关论文
共 50 条
  • [1] Phase II Study of the Triple Combination Chemotherapy of SOXIRI (S-1/Oxaliplatin/Irinotecan) in Patients with Unresectable Pancreatic Ductal Adenocarcinoma
    Akahori, Takahiro
    Sho, Masayuki
    Yanagimoto, Hiroaki
    Satoi, Sohei
    Nagai, Minako
    Nishiwada, Satoshi
    Nakagawa, Kenji
    Nakamura, Kota
    Yamamoto, Tomohisa
    Hirooka, Satoshi
    Yamaki, So
    Ikeda, Naoya
    ONCOLOGIST, 2019, 24 (06): : 749 - E224
  • [2] A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer
    Oh, Sung Yong
    Kwon, Hyuk-Chan
    Jeong, Sang-Ho
    Joo, Young-Tae
    Lee, Young-Joon
    Cho, Su Hee
    Kang, Myoung Hee
    Go, Se-il
    Lee, Gyeong-won
    Kim, Hoon Gu
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 350 - 356
  • [3] A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer
    Sung Yong Oh
    Hyuk-Chan Kwon
    Sang-Ho Jeong
    Young-Tae Joo
    Young-Joon Lee
    Su hee Cho
    Myoung Hee Kang
    Se-il Go
    Gyeong-won Lee
    Hoon gu Kim
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 350 - 356
  • [4] PHASE II STUDY WITH DOCETAXEL, OXALIPLATIN AND S-1 COMBINATION CHEMOTHERAPY FOR PATIENTS WITH METASTATIC GASTRIC CANCER
    Zang, D. Y.
    Kang, Y.
    Ryoo, B.
    Ryu, M.
    Lee, S. S.
    Song, H. H.
    Jung, J. Y.
    Kwon, J. H.
    Kim, H. S.
    Choi, D. R.
    ANNALS OF ONCOLOGY, 2010, 21 : 261 - 261
  • [5] Phase II study of SOXIRI (S-1/oxaliplatin/irinotecan) chemotherapy in patients with unresectable pancreatic ductal adenocarcinoma
    Wang, Fenghua
    Wang, Yixing
    Ren, Chao
    Li, Xujia
    Qiu, Miaozhen
    Li, Yuhong
    Luo, Huiyan
    Peng, Ruojun
    Quan, Qi
    Jiang, Qi
    Li, Shengping
    Guo, Guifang
    PANCREATOLOGY, 2024, 24 (02) : 241 - 248
  • [6] Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer
    Sung Yong Oh
    Young-Tae Ju
    Sang-Kyung Choi
    Chang Yoon Ha
    Won Sup Lee
    Hoon Gu Kim
    Gyeong-Won Lee
    Hyuk-Chan Kwon
    Jung Hun Kang
    Investigational New Drugs, 2011, 29 : 1050 - 1056
  • [7] Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer
    Oh, Sung Yong
    Ju, Young-Tae
    Choi, Sang-Kyung
    Ha, Chang Yoon
    Lee, Won Sup
    Kim, Hoon Gu
    Lee, Gyeong-Won
    Kwon, Hyuk-Chan
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 1050 - 1056
  • [8] PHASE II STUDY WITH DOCETAXEL, OXALIPLATIN AND S-1 (DOS) COMBINATION CHEMOTHERAPY FOR PATIENTS WITH METASTATIC GASTRIC CANCE
    Zang, D.
    Kang, Y.
    Ryoo, B.
    Ryu, M.
    Lee, S.
    Song, H.
    Kim, H.
    Jung, J.
    Kim, J.
    Kwon, J.
    Jang, G.
    Kim, H.
    Lee, Y.
    ANNALS OF ONCOLOGY, 2010, 21 : 89 - 89
  • [9] Phase I/II study of novel oral fluoropyrimidine S-1 in combination with oxaliplatin (SOX) as first-line chemotherapy for metastatic colorectal cancer (mCRC)
    Tahara, M.
    Yamada, Y.
    Ohtsu, A.
    Shirao, K.
    Shimada, Y.
    Sasaki, Y.
    Yamamoto, W.
    Satoh, T.
    Okamoto, W.
    Tanigawara, Y.
    EJC SUPPLEMENTS, 2007, 5 (04): : 254 - 254
  • [10] A PHASE II STUDY OF COMBINATION CHEMOTHERAPY WITH S-1 AND OXALIPLATIN IN PATIENTS WITH RECURRENT UNRESECTABLE OR METASTATIC BILIARY CANCER
    Jang, G.
    Kim, T. W.
    Lee, S. S.
    Sym, S. J.
    Lee, J.
    Ryu, M.
    Chang, H. M.
    Kang, Y.
    Lee, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 177 - 177
12345